Ulla Werlauff - RCFM (EN)

Ulla Werlauff

Head of research, physical therapist, MSc, ph.d
ulwe@rcfm.dk
- Project management and supervision
- Measurement instruments
- Method
- Education

Seneste publikationer

Natural History of a Steriod Naive Duchenne Muscular Dystrophy Cohort
Ageing with neuromuscular disease: getting lost in transitions
Progression or Not – A Small Natural History Study of Genetical Confirmed Congenital Myopathies
Working group Sitting in NMDs. 1st Sitting Workshop for neuromuscular disorders Denmark, 30 September – 1 October 2019

Vis alle publikationer

Seneste projekter

Vis alle projekter

Seneste aktiviteter

Koordinator og kontaktperson for oversættelser af EK-skalaen
Deltager i international arbejdsgruppe om udvikling af målemetoder til undersøgelse af bulbær funktion (spise, synke, tale) hos personer med spinal muskelatrofi
Medlem af Medicinrådets fagudvalg for behandling af medicin til spinal muskelatrofi og Duchenne muskeldystrofi
Censor og vejledning, Bachelorstuderende på Fysioterapeut-uddannelse

Vis alle aktiviteter

Publikationer

Natural History of a Steriod Naive Duchenne Muscular Dystrophy Cohort

Birgit F. Steffensen, Jørgen Jeppesen, Ulla Werlauff, Jes Rahbek

Poster

01/10/2021
Ageing with neuromuscular disease: getting lost in transitions

Møller LA, Martinsen B, Werlauff U, Dreyer P

Disabil Rehabil. 2021 Mar 24:1-8.

24/03/2021
Progression or Not – A Small Natural History Study of Genetical Confirmed Congenital Myopathies

Werlauff U, Hansen PD, Witting N, Vissing J

J Neuromuscul Dis. 2021 Feb 19.

19/02/2021
Working group Sitting in NMDs. 1st Sitting Workshop for neuromuscular disorders Denmark, 30 September – 1 October 2019

Groot IJ, Werlauff U

I: Neuromuscul Disord. 2020 Jul;30(7):616-619

01/07/2020
Parents’ Experiences of Information and Decision Making in the Care of Their Child With Severe Spinal Muscular Atrophy

Beernaert K, Lövgren M, Jeppesen J, Werlauff U, Rahbek J, Sejersen T, Kreicbergs U.

J Child Neurol. 2019 Mar;34(4):210-215. doi: 10.1177/0883073818822900. Epub 2019 Jan 15. PMID: 30642225.

01/03/2019
Bereaved Parents More Satisfied With the Care Given to Their Child With Severe Spinal Muscular Atrophy Than Nonbereaved

Hjorth E, Kreicbergs U, Sejersen T, Jeppesen J, Werlauff U, Rahbek J, Lövgren M

I: J Child Neurol. 2019 Feb;34(2):104-112.

01/02/2019
Evaluation of Dynamic Movement otrhoses (DMO) as a means to rellieve pain and fatigue in patients with facio-scapulo-humeral muscular dystrophy (FSHD)

Pia Z. Drivsholm, Torben Nybro, Lene Busk, Ulla Werlauff

Poster

01/10/2018
Collagen XII myopathy with rectus femoris atrophy and collagen XII retention in fibroblasts

Witting N, Krag T, Werlauff U, Duno M, Oestergaard ST, Dahlqvist JR, Vissing J.

I: Muscle Nerve. 2018 Jun; 57(6):1026-1030.

01/06/2018
Congenital titinopathy: Comprehensive characterisation and pathogenic insights.

Oates EC et al.

I: Ann Neurol. 2018 Apr 25.

01/04/2018
Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark

Witting N, Werlauff U, Duno M, Vissing J

I: Neurol Genet. 2017 Mar 21;3(2):e140.

01/03/2017
Upper Limb Clinical Outcome Group. Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM

Klingels K, Mayhew AG, Mazzone ES, Duong T, Decostre V, Werlauff U, Vroom E, Mercuri E, Goemans NM, Dev

I: Med Child Neurol. 2017 Feb;59(2):224-231

01/02/2017
Prevalence and phenotypes of congenital myopathy due to α-actin 1 gene mutations

Witting N, Werlauff U, Duno M, Vissing J,

I: Muscle Nerve. 2016 Mar;53(3):388-93

01/03/2016
Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or ‘classical’ congenital myopathy

Zaharieva IT et al.

I: Brain. 2016 Mar;139(Pt 3):674-91

01/03/2016
Orofacial problems in patients with Duchenne muscular dystrophy and spinal muscular atrophy

Ulla Werlauff, Birgit Fynbo Steffensen, Jes Rahbek

Poster

01/02/2016
Frequency and Phenotype of Myotubular Myopathy Amongst Danish Patients with Congenital Myopathy Older than 5 Years

Werlauff U, Petri, H, Witting N, Vissing, J

I: Neuromuscular Diseases 2 (2015) 167–174

01/02/2015
Parents’ Experiences of Information and Decision Making in the Care of Their Child With Severe Spinal Muscular Atrophy: A Population Survey

Beernaert K, Lövgren M, Jeppesen J, Werlauff U, Rahbek J, Sejersen T, Kreicbergs U

I: J Child Neurol. 2019 Jan 15.

01/01/2015
Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale

Werlauff U, Højberg A, Firla-Holme R, Steffensen BF, Vissing J.

Qual Life Res. 2014 Jun;23(5):1479-88. doi: 10.1007/s11136-013-0565-8. Epub 2013 Nov 9. PMID: 24214178.

23/06/2014
Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy

Citirak G, Witting N, Duno M, Werlauff U, Petri H, Vissing J

I: Neuromuscul Disord. 2014 Apr;24(4):325-30

01/04/2014
Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale

Werlauff U, Højberg A, Firla-Holme R, Steffensen BF

I: Qual life Res 2014; 23 (5)1479-88

01/01/2014
The applicability of four clinical methods to evaluate arm and hand function in all stages of spinal muscular atrophy type II

Werlauff U, Fynbo Steffensen B

I: Disabil Rehabil. 2014;36(25):2120-6

01/01/2014
Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients

Werlauff U, Steffensen BF, Bertelsen S, Fløytrup I, Kristensen B, Werge B.

Neuromuscul Disord. 2010 Jan;20(1):34-43

09/11/2013
Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study

Werlauff U, Vissing J, Steffensen BF

I: Neuromuscul Disord 2012,12:(1069-74)

01/12/2012
Does muscle strength deteriorate in spinal muscular atrophy type 2 and 3

Ulla Werlauff, John Vissing, Birgit F. Steffensen

Poster

01/10/2011
Longitudinal data analysis: an application to construction of a natural history profile of Duchenne muscular dystrophy

Hyde SA, Steffensen BF, Fløytrup I, Glent S, Kroksmark AK, Salling B, Werlauff U, Erlandsen M

I: Neuromuscul Disord. 2001 Mar;11(2):165-70

01/03/2011
A randomized comparative study of two methods for controlling Tendo Achilles contracture in Duchenne muscular dystrophy

Hyde SA, Fløytrup I, Glent S, Kroksmark AK, Salling B, Steffensen BF, Werlauff U, Erlandsen M

I: Neuromuscul Disord. 2000 Jun;10(4-5):257-63

01/06/2010
Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients

Werlauff U, Steffensen BF, Bertelsen S, Floytrup I, Kristensen B, Werge B

I: Neuromuscul Disord. 2010, 20(34-43)

01/01/2010

Projekter

Aktiviteter

Koordinator og kontaktperson for oversættelser af EK-skalaen
Deltager i international arbejdsgruppe om udvikling af målemetoder til undersøgelse af bulbær funktion (spise, synke, tale) hos personer med spinal muskelatrofi
Medlem af Medicinrådets fagudvalg for behandling af medicin til spinal muskelatrofi og Duchenne muskeldystrofi
Censor og vejledning, Bachelorstuderende på Fysioterapeut-uddannelse
2013, kapitelforfatter ”Pædiatrisk fysioterapi”, Munkgaards forlag.
2001, kapitelforfatter ”Det Myasteniske puslespil”, Muskelsvindfonden
Netværk om outcome measures for DMD and SMA

© 2024 RehabiliteringsCenter for Muskelsvind. All rights reserved.

Persondata Cookiepolitik